The Business Research Company's Key Market Driver In Hepagam B industry 2025: Rising Hepatitis B Prevalence To Fueling Growth It will grow to $XX million in 2029 at a compound annual growth rate (CAGR ...

Indaptus Therapeutics (INDP) has secured new patent approvals in China, Japan and Israel for its Decoy platform. These patents cover the use ...

Researchers identify a history of GI bleeding and three other factors as elevating variceal bleeding risk in patients ...

Hologic (NASDAQ:HOLX – Get Free Report) had its price target lowered by analysts at Citigroup from $80.00 to $70.00 in a ...

Hologic, Inc. (NASDAQ:HOLX – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday after Citigroup ...

Fourth quarter and full year 2024 BRIUMVI U.S. net revenue of $103.6 million and $310 million, respectivelyTarget guidance of approximately $540 ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

A successful blood borne virus (BBV) opt-out testing programme is being expanded across NHS Greater Manchester emergency ...

The global DNA diagnostics market is on an impressive growth trajectory, with sales projected to reach USD 27,094.2 million in 2024, and further expanding to USD 57,420.1 million by 2034. This surge ...

Rising rates of metabolic dysfunction–associated steatohepatitis indicate a need for public health interventions.

From the column: "Health care providers are battling the storm, on a seemingly impossible quest to repair the tattered mess ...

Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...